Vaginal and Vulval Inflammatory Disease Treatment Market SWOT Analysis 2023 to 2033
The market for treating Vaginal and Vulval Inflammatory Disease Treatment is expected to reach US$ 2.96 billion in fiscal year 2023, up from US$ 2.8 billion in fiscal year 2022. The global market is expected to grow steadily at a 5.8% CAGR between 2023 and 2033, reaching a value of US$ 5.21 billion by the end of that year. Among the symptoms of Vaginal and vulval inflammation are swelling around the vagina, heat when urinating, whitish-gray vaginal discharge, and clumpy vaginal discharge. Candidiasis, a yeast infection, can irritate the vaginal lining. A healthy vagina is made up of bacteria and a small number of yeast cells, but when the ratio of bacteria to yeast changes, these yeast cells or other microorganisms have the potential to grow, causing swelling, acute stinging, and irritation. According to CDC estimates, 42%-45% of women may experience this illness twice or more per year, and approximately three-fourths of women are expected to develop Vaginal and vulval inflammati...